Repression of retrovirus-mediated transgene expression by interferons: Implications for gene therapy

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9163-9169

  Ghazizadeh, Soosan ^a   Carroll, Joseph M ^b,c   Taichman, Lorne B ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA GALACTOSIDASE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INVOLUCRIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPORTER GENE; RETROVIRUS; RNA SYNTHESIS; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; TRANSGENE; VIRUS RECOMBINANT;

EID: 0030729199     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9163-9169.1997     Document Type: Article

References (52)

1. Besancon, F., G. Przewlocki, I. Baro, A.-S. Hongre, D. Escande, and A. Edelman. 1994. Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am. J. Physiol. 267:C1398-C1404.
2. Carroll, J. M., K. M. Albers, J. A. Garlick, R. Harrington, and L. B. Taichman. 1993. Tissue-and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc. Natl. Acad. Sci. USA 90:10270-10274.
3. Challita, P.-M., and D. B. Kohn. 1994. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91:2567-2571.
4. Choate, K. A., D. A. Medalie, J. R. Morgan, and P. A. Khavari. 1996. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2:1263-1267.
5. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. Collins, T., L. A. Lapierre, W. Fiers, J. L. Strominger, and J. S. Pober. 1986. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83:446-450.
7. Cullen, B. R., P. T. Lomedico, and G. Ju. 1984. Transcriptional interference in avian retroviruses - implications for the promoter insertion model of leukaemogenesis. Nature 307:241-245.
8. Dani, C., N. Mechti, M. Peichaczyk, B. Lebleu, P. Jeanteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc mRNA in interteron-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896-1899.
9. Danos, O., and R. C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85:6460-6464.
10. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
11. David, M. 1995. Transcription factors in interferon signaling. Pharmacol. Ther. 65:149-161.
12. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenic mechanism. Cell 39:459-467.
13. Emilie, D., M. C. Maillot, J.-F. Nicolas, R. Fior, and P. Galanaud. 1992. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat. J. Biol. Chem. 267:20565-20570.
14. Fenjves, E. S., S.-N. Yao, K. Kurachi, and L. B. Taichman. 1996. Analysis of loss of expression of a retrovirus-transduced gene in grafted human keratinocytes. J. Invest. Dermatol. 106:576-578.
15. Fujita, T., L. F. L. Reis, N. Watanabe, Y. Kimura, and T. Taniguchi. 1989. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of the second-messenger pathways. Proc. Natl. Acad. Sci. USA 86:9936-9940.
16. Gerrard, A. J., D. L. Hudson, G. G. Brownlee, and F. M. Watt. 1993. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. 3:180-183.
17. Gribaudo, G., S. Ravaglia, A. Caliendo, R. Cavallo, M. Gariglio, M. G. Martinotti, and S. Landolfo. 1993. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197:303-311.
18. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
19. Harms, J. S., and G. A. Splitter. 1995. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6:1291-1297.
20. Hertle, M. D., P. H. Jones, R. W. Groves, D. L. Hudson, and F. M. Watt. 1995. Integrin expression by human epidermal keratinocytes can be modulated by interferon-gamma, transforming growth factor-beta, tumor necrosis factor-alpha, and culture on a dermal equivalent. J. Invest. Dermatol. 104: 260-265.
21. Hoeben, R. C., A. A. Migchielsen, R. C. van der Jagt, H. van Ormondt, and A. J. van der Eb. 1991. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65:904-912.
22. Horvath, C. M., and J. E. Darnell, Jr. 1996. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J. Virol. 70:647-650.
23. Jackson, R. J. 1993. Cytoplasmic regulation of mRNA function: the importance of the 3′ untranslated region. Cell 74:9-14.
24. Jaffee, E. M., G. Dranoff, L. K. Cohen, K. M. Hauda, S. Clift, F. F. Marshall, R. C. Mulligan, and D. M. Pardoll. 1993. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res. 53:2221-2226.
25. Kaleko, M., J. V. Garcia, and A. D. Miller. 1991. Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2:27-32.
26. Kay, M. A., P. Baley, S. Rothenberg, F. Leland, L. Fleming, K. P. Parker, T.-J. Liu, M. Finegold, G. Darlington, W. Pokorny, et al. 1992. Expression of human α1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89:89-93.
27. Kerr, I. M., and G. R. Stark. 1992. The antiviral effects of the interferons and their inhibition. J. Interferon Res. 12:237-240.
28. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400-406.
29. Marzluff, W. F., and R. C. C. Huang. 1984. Transcription of RNA in isolated nuclei, p. 89-129. In B. D. Hames and S. J. Higgins (ed.), Transcription and translation: a practical approach. IRL Press, Oxford, England.
30. McCune, S. L., and T. M. Townes. 1994. Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. Nucleic Acids Res. 22:4477-4481.
31. Melton, D. A., P. A. Krieg, R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes for plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
32. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323:816-819.
33. Miller, A. D. 1992. Retroviral vectors. Curr. Top. Microbiol. Immunol. 158: 3-24.
34. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor. IRF-1. that specifically binds to IFN-beta gene regulatory elements. Cell 54:903-913.
35. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
36. Ng, R. L. H., B. Woodward, S. Bevan, C. Green, and R. Martin. 1997. Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium. J. Invest. Dermatol. 108:457-462.
37. NIH Recombinant DNA Advisory Committee. 1996. Human gene therapy clinical protocols. Hum. Gene Ther. 7:565-568.
38. Nilsen, T. W., P. A. Maroney, and C. Baglioni. 1982. Synthesis of (2′-5′)oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 42:1039-1045.
39. Palmer, T. D., G. L. Rosman, W. R. Osborne, and A. D. Miller. 1991. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88:1330-1334.
40. Palmer, T. D., A. R. Thompson, and A. D. Miller. 1989. Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73:438-445.
41. Radzioch, D., and L. Varesio. 1991. c-fos mRNA expression in macrophages is downregulated by interferon-γ at the posttranscriptional level. Mol. Cell. Biol. 11:2718-2722.
42. Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinocyte colonies from single cells. Cell 6:331-344.
43. Richards, C. A., and B. E. Huber. 1993. Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum. Gene Ther. 4:143-50.
44. Riviere, I., K. Brose, and R. C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733-6737.
45. Samuel, C. E. 1991. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11.
46. Scharfmann, R., J. H. Alexrod, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626-4630.
47. Stead, R. B., W. W. Kwok, R. Storb, and A. D. Miller. 1988. Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors. Blood 71:742-747.
48. Stockschlader, M. A., F. G. Schuening, T. C. Graham, and R. Storb. 1994. Transplantation of retrovirus-transduced canine keratinocytes expressing the β-galactosidase gene. Gene Ther. 1:317-322.
49. Strauss, M. 1994. Liver-directed gene therapy: prospects and problems. Gene Ther. 1:156-164.
50. Tsui, L. V., L. G. Guidotti, T. Ishikawa, and F. V. Chisari. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA 92:12398-12402.
51. Wu, Y.-J., L. M. Parker, N. E. Binder, M. A. Beckett, J. H. Sinard, C. T. Griffiths, and J. G. Rheinwald. 1982. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells nonkeratinizing epithelia. Cell 31:693-703.
52. Yee, J. K., J. C. Moores, D. J. Jolly, J. A. Wolf, J. G. Respess, and T. Friedmann. 1987. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84:5197-5201.